Highest EBITDA
legend_toggleExplore a diverse array of industries, each represented by companies that have excelled in generating substantial EBITDA.
| name | PRICE | $ CHANGE | % CHANGE | MARKET CAP | VOLUME | AVG. VOLUME | arrow_downwardEBITDA | TECHNICALS | DIVIDEND Y | ROI 1Y | Score language | LAST 7 DAYS | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GRTSGritstone Oncology | $0.63 | $0.08 | arrow_drop_up14.54% | $66.16M | 1.96M | 980.62K | -$129.23M | Neutralremove | - | -54.34% | AI Analysis | |||||
TNGXTango Therapeutics | $8.41 | $0.13 | arrow_drop_up1.57% | $895.72M | 890.30K | 1.70M | -$129.95M | Neutralremove | - | -1.29% | AI Analysis | |||||
KPTIKaryopharm Therapeutics | $0.73 | $0.00 | arrow_drop_up0.27% | $91.82M | 453.90K | 411.84K | -$130.61M | Neutralremove | - | -37.89% | AI Analysis | |||||
SAVACassava Sciences | $30.36 | $0.04 | arrow_drop_up0.13% | $1.45B | 1.31M | 1.62M | -$130.64M | Neutralremove | - | 133.53% | AI Analysis | |||||
GLUEMonte Rosa Therapeutics | $6.25 | $0.30 | arrow_drop_up5.04% | $363.32M | 214.30K | 234.75K | -$131.78M | Neutralremove | - | 3.47% | AI Analysis | |||||
PRAXPraxis Precision Medicines | $63.02 | $3.64 | arrow_drop_up6.13% | $1.03B | 289.90K | 235.40K | -$132.25M | Neutralremove | - | 183.87% | AI Analysis | |||||
 BRZEBraze, Inc. Class A Common Stock | $36.39 | $1.40 | arrow_drop_up4.00% | $3.69B | 1.39M | 1.65M | -$132.41M | Neutralremove | - | -21.21% | AI Analysis | |||||
EVTLVertical Aerospace Ltd. | $0.72 | -$0.06 | arrow_drop_down7.65% | $173.87M | 937.20K | 559.62K | -$132.97M | Neutralremove | - | -50.74% | AI Analysis | |||||
NPWRNet Power | $7.07 | $0.35 | arrow_drop_up5.20% | $514.49M | 1.45M | 555.48K | -$133.24M | Neutralremove | - | -55.78% | AI Analysis | |||||
CSSEChicken Soup For The Soul Entertainment | $0.01 | $0.00 | arrow_drop_up6.11% | $3.42M | 34.43K | 69.66K | -$133.95M | Buykeyboard_arrow_up | - | -96.83% | AI Analysis | |||||
EWTXEdgewise Therapeutics | $29.50 | $10.43 | arrow_drop_up54.69% | $1.69B | 11.92M | 2.21M | -$134.28M | Neutralremove | - | 378.11% | AI Analysis | |||||
PRTCPureTech Health plc | $19.43 | $0.01 | arrow_drop_up0.07% | $469.13M | 2.70K | 10.92K | -$134.72M | Neutralremove | - | -32.82% | AI Analysis | |||||
LICYLi-Cycle Holdings | $2.42 | $0.30 | arrow_drop_up14.15% | $45.93M | 1.91M | 1.01M | -$135.50M | Neutralremove | - | -92.62% | AI Analysis | |||||
TNDMTandem Diabetes Care | $44.45 | $1.81 | arrow_drop_up4.24% | $2.79B | 939.60K | 978.04K | -$136.93M | Neutralremove | - | 101.77% | AI Analysis | |||||
ADCTADC Therapeutics SA | $3.21 | $0.11 | arrow_drop_up3.54% | $313.13M | 326.30K | 310.92K | -$137.47M | Neutralremove | - | 301.25% | AI Analysis | |||||
CRBUCaribou Biosciences | $2.07 | -$0.01 | arrow_drop_down0.48% | $195.18M | 732.50K | 1.03M | -$137.69M | Neutralremove | - | -62.01% | AI Analysis | |||||
ITOSiTeos Therapeutics | $11.22 | -$0.37 | arrow_drop_down3.19% | $442.46M | 832.60K | 1.39M | -$139.26M | Neutralremove | - | -10.31% | AI Analysis | |||||
PRLDPrelude Therapeutics Incorporated | $2.55 | $0.11 | arrow_drop_up4.50% | $143.06M | 800.90K | 639.53K | -$140.78M | Neutralremove | - | -16.93% | AI Analysis | |||||
CMPSCOMPASS Pathways plc | $7.40 | $0.10 | arrow_drop_up1.36% | $508.12M | 385.60K | 316.21K | -$141.30M | Neutralremove | - | -14.84% | AI Analysis | |||||
RKLBRocket Lab USA | $7.17 | $0.05 | arrow_drop_up0.70% | $3.66B | 10.50M | 11.08M | -$141.32M | Neutralremove | - | 53.86% | AI Analysis |
Showing 4761-4780 of 4977
Results per page:
About Highest EBITDA
Discover the stocks with the highest EBITDA, a significant financial metric indicating a company's operational profitability. EBITDA, or earnings before interest, taxes, depreciation, and amortization, reflects a firm's ability to generate profits from its core operations without factoring in financing and accounting decisions.
Investors seek companies with robust EBITDA figures as it showcases their potential for sustainable growth and cash flow generation. High EBITDA stocks often demonstrate strong financial health and efficiency, making them attractive choices for long-term investment strategies.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools